Latest Period
Q2 2026
Security Snapshot
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) Institutional Ownership
CUSIP: 19243B102
13F Institutional Holders and Ownership History from Q4 2021 to Q2 2026
Institutions Reporting
66
Shares (Excl. Options)
22,587,135
Price
$1.15
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- CGTX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 22,587,135
- Total 13F value
- $25,972,513
- Portfolio coverage rank
- 0%
- Share change
- +1,167,442
- Value change
- +$1,646,508
- Number of holders
- 66
- Shares outstanding
- 87,819,638
- SEC-reported price per share
- $0.95
- Insider filing price
- $0.95
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share is tracked under CUSIP 19243B102.
- 66 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 74 to 66 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $16,261,960 to $25,972,513.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 66 institutions filings for Q2 2026.
Security key
19243B102
Latest holder period
Q2 2026
13F holders
66
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
CGTX full holder history
COGNITION THERAPEUTICS INC SEC filings
COGNITION THERAPEUTICS INC company facts
COGNITION THERAPEUTICS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 19243B102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
CGTX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOS Memory SPV I, LP | 6.9% | $15,027,696 | 6,059,555 | AARON G.L. FLETCHER | 19 Sep 2025 |
As of 30 Jun 2026, 66 institutional investors reported holding 22,587,135 shares of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX). This represents 26% of the company’s total 87,819,638 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
25%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 6.8% | 6,000,000 | 0% | 17% | $6,900,001 |
| DAVENPORT & Co LLC | 4.9% | 4,259,511 | +47% | 0.03% | $4,898,438 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 3,438,775 | +15% | 0% | $3,954,591 |
| BlackRock, Inc. | 1.4% | 1,261,993 | +30% | 0% | $1,451,292 |
| Chescapmanager LLC | 1.1% | 997,029 | 0% | 0.15% | $1,146,583 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 910,006 | -1.1% | 0% | $1,047,051 |
| RENAISSANCE TECHNOLOGIES LLC | 0.79% | 693,288 | -38% | 0% | $797,281 |
| Hilton Capital Management, LLC | 0.63% | 548,950 | 0% | 0.04% | $631,293 |
| VANGUARD FIDUCIARY TRUST CO | 0.58% | 508,220 | +9.6% | 0% | $584,453 |
| CM Management, LLC | 0.51% | 450,000 | +12% | 0.33% | $517,500 |
| Dauntless Investment Group, LLC | 0.42% | 371,701 | -14% | 0.74% | $427,456 |
| Sigma Planning Corp | 0.41% | 362,265 | +7.3% | 0.01% | $416,605 |
| STATE STREET CORP | 0.4% | 348,983 | +11% | 0% | $401,330 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.36% | 320,500 | +64% | 0% | $368,575 |
| UBS Group AG | 0.25% | 218,536 | +184% | 0% | $251,316 |
| AMERICAN FINANCIAL GROUP INC | 0.23% | 205,000 | 0% | 0.08% | $235,750 |
| NORTHERN TRUST CORP | 0.2% | 178,202 | +5.6% | 0% | $204,932 |
| Voss Capital, LP | 0.2% | 175,000 | -12% | 0.01% | $201,250 |
| Texas Capital Bank Wealth Management Services Inc | 0.16% | 143,296 | +16% | 0.01% | $164,790 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.1% | 84,940 | 0% | 0% | $97,681 |
| Virtu Financial LLC | 0.1% | 83,434 | +19% | 0% | $96,000 |
| XTX Topco Ltd | 0.09% | 78,471 | -60% | 0% | $90,242 |
| Corient Private Wealth LP | 0.09% | 78,226 | +8.5% | 0% | $89,960 |
| McAdam, LLC | 0.07% | 64,553 | -7.7% | 0% | $74,236 |
| FCA CORP /TX | 0.06% | 52,536 | 0% | 0.01% | $60,416 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
19
Latest
Q2 2026
Rows shown
1-19 of 19
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 22,587,135 | $25,972,513 | +$1,646,508 | $1.15 | 66 |
| 2026 Q1 | 21,406,784 | $16,261,960 | -$482,537 | $0.76 | 74 |
| 2025 Q4 | 21,425,389 | $28,929,187 | +$212,111 | $1.35 | 79 |
| 2025 Q3 | 21,268,922 | $28,723,974 | +$14,962,053 | $1.35 | 68 |
| 2025 Q2 | 11,168,930 | $3,463,844 | -$159,050 | $0.31 | 45 |
| 2025 Q1 | 11,627,581 | $4,889,933 | +$37,435 | $0.42 | 48 |
| 2024 Q4 | 11,088,340 | $7,775,058 | +$595,627 | $0.70 | 44 |
| 2024 Q3 | 4,253,980 | $1,990,924 | -$2,451,158 | $0.47 | 39 |
| 2024 Q2 | 5,310,353 | $8,815,784 | -$2,998,367 | $1.66 | 46 |
| 2024 Q1 | 7,090,800 | $12,904,468 | -$197,637 | $1.82 | 46 |
| 2023 Q4 | 7,154,013 | $13,234,773 | +$56,992 | $1.85 | 36 |
| 2023 Q3 | 7,236,396 | $10,419,453 | +$193,944 | $1.44 | 34 |
| 2023 Q2 | 7,100,887 | $12,994,058 | -$80,887 | $1.83 | 34 |
| 2023 Q1 | 7,140,406 | $14,140,001 | +$282,877 | $1.98 | 32 |
| 2022 Q4 | 4,800,813 | $10,080,423 | +$4,062,100 | $2.10 | 32 |
| 2022 Q3 | 5,091,352 | $9,669,716 | +$1,037,445 | $1.90 | 29 |
| 2022 Q2 | 4,504,385 | $9,489,895 | +$5,791,733 | $2.11 | 27 |
| 2022 Q1 | 1,666,005 | $4,577,000 | +$779,768 | $2.75 | 25 |
| 2021 Q4 | 1,334,704 | $8,437,000 | +$8,437,000 | $6.32 | 18 |